Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.2K Hold
134
﹤0.01% 252
2025
Q4
$34.3K Hold
134
0.01% 231
2025
Q3
$35K Hold
134
0.01% 232
2025
Q2
$33K Hold
134
0.01% 231
2025
Q1
$35K Hold
134
0.01% 223
2024
Q4
$34K Hold
134
0.01% 194
2024
Q3
$42K Hold
134
0.01% 176
2024
Q2
$50K Hold
134
0.01% 158
2024
Q1
$46K Hold
134
0.01% 164
2023
Q4
$61K Hold
134
0.02% 144
2023
Q3
$65K Hold
134
0.02% 129
2023
Q2
$60K Hold
134
0.02% 142
2023
Q1
$65K Hold
134
0.02% 134
2022
Q4
$69K Hold
134
0.02% 135
2022
Q3
$65K Hold
134
0.02% 136
2022
Q2
$63K Hold
134
0.02% 143
2022
Q1
$58K Hold
134
0.02% 171
2021
Q4
$62K Hold
134
0.02% 170
2021
Q3
$52K Buy
+134
New +$56.9K 0.01% 183

Other funds holding HUM

Canton Hathaway's HUM Position: Q1 2026 in Review

Canton Hathaway held its Humana (HUM) position steady in Q1 2026 at 134 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Canton Hathaway first reported a position in HUM in Q3 2021 and has held it in 19 quarters since. The position peaked at $69K in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Canton Hathaway held 134 shares of Humana worth $23.2K as of Q1 2026.
  • Canton Hathaway left its Humana share count unchanged in Q1 2026.
  • Humana made up ﹤0.01% of Canton Hathaway's portfolio in Q1 2026, its #252 holding.
  • Canton Hathaway first reported a position in Humana in Q3 2021 and has held it in 19 quarters since.
  • Canton Hathaway's Humana position peaked at $69K in Q4 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Canton Hathaway's 13F filing for Q1 2026, filed 24 Apr 2026.